Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Healthy Ageing.

Networking events, like AIMdays, are one of the ways in which we bring together innovative companies and world-leading academics.

The University of Oxford, together with the UK SPINE Knowledge Exchange, will be hosting an AIMday in Healthy Ageing on Wednesday 9 October 2019 at Blavatnik School of Government. This event will bring together industry with academia to discuss the healthcare challenges associated with ageing. The UK Spine initiative aims to accelerate innovations in ageing and the AIMday will draw on expertise from all the UK Spine’s partners: the University of Oxford, the University of Dundee, the University of Birmingham, the Medicines Discovery Catapult and the Francis Crick Institute.

FREE registration for academics is now open and closes on Friday 27 September (advance registration is essential).

A range of companies including Five Alarm Bio, Isansys, Kemuri, Shift Bioscience (& more) are registered to attend the event and it will be a fantastic opportunity for researchers looking to network with industry and discuss relevant questions.

To see the questions posed by these companies, please visit aimday.se/healthy-ageing-oxford-2019/questions-listing.

Register here: aimday.se/healthy-ageing-oxford-2019/registration-for-researchers

Similar stories

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.

Opportunities for final goodbyes must be prioritised in COVID-19 pandemic

Coronavirus COVID-19 General Research

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.

New study shows overwhelming public support for donating vaccines to low-income countries

Coronavirus COVID-19 General Research

A survey led by Nuffield Department of Population Health's Health Economics Research Centre has found that most people in high-income countries support donating some of their country’s COVID-19 vaccine supplies to low-income nations who would otherwise struggle to gain access.